Newsroom

Newsroom

Press Releases
Events & Presentations
News Articles
Media Center

Recent Press Releases

April 28, 2025

Frontier Medicines Unveils New Preclinical Data for FMC-220, a First-in-Class Covalent p53 Y220C Activator, at AACR 2025

February 27, 2025

Frontier Medicines to Participate in Two Upcoming March Investor Conferences

January 9, 2025

Frontier Medicines Announces FMC-220, the First Covalent p53 Y220C Activator Development Candidate, with Best-in-Class Potential

Read All Press Releases

Events & Presentations

UPCOMING EVENTS

There are currently no upcoming events scheduled

Select Media Coverage

April 11, 2024

Fierce Biotech: AACR: Verastem, Quanta and Frontier demonstrate KRAS inhibitors' potential in preclinical data

February 22, 2024

Fierce Biotech: Frontier CEO weathers 'one of the hardest financings' of his career to close $80M series C

February 22, 2024

San Francisco Business Times: Peninsula biotech raises $80M as it doses 1st person in 1st clinical trial

Media Center

Media Contact

Contact PR Team

Logos
Click on the links below to download a high resolution image of the Frontier Medicines logo